EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 147 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $337,320 | -61.1% | 21,390 | -52.0% | 0.00% | – |
| Q2 2023 | $866,091 | -27.3% | 44,552 | +6.1% | 0.00% | -100.0% |
| Q1 2023 | $1,191,455 | -6.4% | 41,997 | -3.5% | 0.00% | 0.0% |
| Q4 2022 | $1,272,499 | +21.8% | 43,534 | +10.1% | 0.00% | 0.0% |
| Q3 2022 | $1,045,000 | -41.0% | 39,556 | -0.8% | 0.00% | 0.0% |
| Q2 2022 | $1,771,000 | -10.4% | 39,860 | -0.2% | 0.00% | 0.0% |
| Q1 2022 | $1,977,000 | -4.7% | 39,949 | -1.9% | 0.00% | 0.0% |
| Q4 2021 | $2,074,000 | -8.7% | 40,733 | +0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,271,000 | +25.5% | 40,722 | -3.7% | 0.00% | 0.0% |
| Q2 2021 | $1,810,000 | +23.5% | 42,279 | +20.4% | 0.00% | 0.0% |
| Q1 2021 | $1,466,000 | +10.3% | 35,122 | +23.1% | 0.00% | 0.0% |
| Q4 2020 | $1,329,000 | +3.5% | 28,532 | -5.6% | 0.00% | 0.0% |
| Q3 2020 | $1,284,000 | -23.5% | 30,232 | -13.6% | 0.00% | 0.0% |
| Q2 2020 | $1,679,000 | +4.2% | 34,990 | -0.1% | 0.00% | 0.0% |
| Q1 2020 | $1,612,000 | -24.7% | 35,040 | -1.7% | 0.00% | 0.0% |
| Q4 2019 | $2,141,000 | +6.5% | 35,640 | +0.3% | 0.00% | 0.0% |
| Q3 2019 | $2,010,000 | -4.8% | 35,540 | -6.3% | 0.00% | 0.0% |
| Q2 2019 | $2,112,000 | +12.9% | 37,940 | +2.4% | 0.00% | 0.0% |
| Q1 2019 | $1,871,000 | +12.8% | 37,060 | -10.0% | 0.00% | 0.0% |
| Q4 2018 | $1,658,000 | -45.4% | 41,160 | -6.1% | 0.00% | -50.0% |
| Q3 2018 | $3,038,000 | -8.3% | 43,820 | +0.0% | 0.00% | 0.0% |
| Q2 2018 | $3,314,000 | +247.0% | 43,800 | +141.7% | 0.00% | +100.0% |
| Q1 2018 | $955,000 | -44.3% | 18,118 | -43.6% | 0.00% | 0.0% |
| Q4 2017 | $1,715,000 | +0.9% | 32,110 | +12.6% | 0.00% | 0.0% |
| Q3 2017 | $1,700,000 | -27.6% | 28,510 | -4.2% | 0.00% | -50.0% |
| Q2 2017 | $2,349,000 | +95.3% | 29,770 | +105.3% | 0.00% | +100.0% |
| Q1 2017 | $1,203,000 | -2.8% | 14,500 | -7.1% | 0.00% | 0.0% |
| Q4 2016 | $1,238,000 | +13.4% | 15,600 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $1,092,000 | +80.5% | 15,600 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $605,000 | -4.3% | 15,600 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $632,000 | -53.4% | 15,600 | +2.0% | 0.00% | 0.0% |
| Q4 2015 | $1,357,000 | +17.0% | 15,300 | -2.4% | 0.00% | 0.0% |
| Q3 2015 | $1,160,000 | -8.7% | 15,670 | -0.2% | 0.00% | 0.0% |
| Q2 2015 | $1,270,000 | – | 15,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
| TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
| Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
| Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
| Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |